Platelets induce VISTA expression and modulate the ovarian tumor microenvironment

Area of Science:

• Immunology
• Oncology
• Hematology

Background:

• Immune checkpoint regulators like V-domain Ig suppressor of T cell activation (VISTA) are crucial in tumor immune evasion.
• VISTA is highly expressed in ovarian cancer, exceeding Programmed Death-Ligand 1 (PD-L1) levels.
• The role of platelets in regulating VISTA in ovarian cancer remains underexplored.

Purpose of the Study:

• To investigate the role of platelets in regulating VISTA expression in ovarian cancer.
• To determine the impact of platelet-mediated VISTA upregulation on the tumor microenvironment (TME).

Main Methods:

• Utilized in vitro and in vivo models of ovarian cancer.
• Assessed VISTA expression in myeloid and tumor cells.
• Correlated VISTA levels with platelet counts and clinical outcomes.

Main Results:

• Platelets were found to upregulate VISTA expression in both myeloid and tumor cells.
• This upregulation promotes an immunosuppressive TME in ovarian cancer.
• Elevated VISTA levels correlated with increased platelet counts and poorer patient outcomes.

Conclusions:

• Platelets significantly contribute to VISTA upregulation in ovarian cancer.
• Platelet-mediated VISTA induction creates an immunosuppressive TME.
• Targeting the platelet-VISTA axis presents a potential therapeutic strategy for ovarian cancer.